 Yuhuan Luo
Concepts (117)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bile Ducts, Extrahepatic | 1 | 2021 | 20 | 0.680 |
Why?
| | Immunoglobulin M | 1 | 2021 | 284 | 0.610 |
Why?
| | Biliary Atresia | 1 | 2021 | 158 | 0.600 |
Why?
| | Autoantibodies | 1 | 2021 | 1504 | 0.390 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 3 | 2017 | 210 | 0.280 |
Why?
| | Cyclin-Dependent Kinase 8 | 1 | 2025 | 50 | 0.230 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2025 | 167 | 0.210 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2017 | 233 | 0.210 |
Why?
| | Cerebellar Neoplasms | 1 | 2025 | 177 | 0.200 |
Why?
| | Medulloblastoma | 1 | 2025 | 215 | 0.200 |
Why?
| | Protein Biosynthesis | 1 | 2025 | 458 | 0.190 |
Why?
| | Diabetic Nephropathies | 2 | 2017 | 318 | 0.180 |
Why?
| | Kidney Diseases | 2 | 2017 | 427 | 0.180 |
Why?
| | Portoenterostomy, Hepatic | 1 | 2021 | 43 | 0.170 |
Why?
| | Fluorescent Antibody Technique | 1 | 2021 | 370 | 0.160 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2025 | 1462 | 0.150 |
Why?
| | Kidney | 2 | 2017 | 1496 | 0.150 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 851 | 0.140 |
Why?
| | Bile Acids and Salts | 2 | 2017 | 164 | 0.140 |
Why?
| | Desoxycorticosterone Acetate | 1 | 2017 | 4 | 0.130 |
Why?
| | Relaxin | 1 | 2017 | 18 | 0.130 |
Why?
| | PQQ Cofactor | 1 | 2016 | 5 | 0.130 |
Why?
| | Cholic Acids | 1 | 2015 | 13 | 0.120 |
Why?
| | Cell Line | 1 | 2021 | 2882 | 0.110 |
Why?
| | Renal Insufficiency | 1 | 2017 | 169 | 0.110 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 338 | 0.100 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2016 | 266 | 0.100 |
Why?
| | Heart | 1 | 2017 | 636 | 0.100 |
Why?
| | Sumoylation | 1 | 2013 | 18 | 0.100 |
Why?
| | Lipid Metabolism | 1 | 2017 | 528 | 0.100 |
Why?
| | Disease Progression | 1 | 2021 | 2852 | 0.100 |
Why?
| | Antioxidants | 1 | 2016 | 549 | 0.100 |
Why?
| | Obesity | 2 | 2016 | 3082 | 0.090 |
Why?
| | Myocardium | 1 | 2017 | 939 | 0.090 |
Why?
| | Transcriptional Activation | 1 | 2013 | 383 | 0.080 |
Why?
| | Lysine | 1 | 2013 | 302 | 0.080 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2016 | 675 | 0.080 |
Why?
| | Hypertension | 1 | 2017 | 1264 | 0.070 |
Why?
| | Gene Expression Regulation | 2 | 2013 | 2609 | 0.060 |
Why?
| | Infant | 1 | 2021 | 10039 | 0.060 |
Why?
| | Aging | 1 | 2017 | 1966 | 0.060 |
Why?
| | Child, Preschool | 1 | 2021 | 11799 | 0.060 |
Why?
| | Podocytes | 2 | 2017 | 80 | 0.060 |
Why?
| | CRISPR-Cas Systems | 1 | 2025 | 170 | 0.050 |
Why?
| | Transcription, Genetic | 2 | 2025 | 1496 | 0.050 |
Why?
| | Mice | 5 | 2025 | 18365 | 0.050 |
Why?
| | Animals | 7 | 2025 | 38109 | 0.050 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2025 | 930 | 0.050 |
Why?
| | ATP-Binding Cassette Transporters | 2 | 2013 | 118 | 0.050 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2025 | 451 | 0.050 |
Why?
| | RNA Polymerase II | 1 | 2025 | 351 | 0.050 |
Why?
| | Mice, Inbred C57BL | 3 | 2017 | 5997 | 0.040 |
Why?
| | Oxidative Stress | 2 | 2016 | 1339 | 0.040 |
Why?
| | Humans | 7 | 2025 | 144957 | 0.040 |
Why?
| | Promoter Regions, Genetic | 2 | 2013 | 1258 | 0.030 |
Why?
| | Male | 3 | 2021 | 72406 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2025 | 3550 | 0.030 |
Why?
| | Mitochondrial Turnover | 1 | 2017 | 5 | 0.030 |
Why?
| | Heart Function Tests | 1 | 2017 | 59 | 0.030 |
Why?
| | Urinalysis | 1 | 2017 | 80 | 0.030 |
Why?
| | Kidney Function Tests | 1 | 2017 | 157 | 0.030 |
Why?
| | Sodium-Glucose Transporter 2 | 1 | 2017 | 29 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2017 | 299 | 0.030 |
Why?
| | Hypolipidemic Agents | 1 | 2017 | 88 | 0.030 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2016 | 162 | 0.030 |
Why?
| | Liver | 2 | 2016 | 1888 | 0.030 |
Why?
| | Cyclooxygenase 2 | 1 | 2016 | 165 | 0.030 |
Why?
| | Ceramides | 1 | 2016 | 116 | 0.030 |
Why?
| | Caloric Restriction | 1 | 2017 | 127 | 0.030 |
Why?
| | PPAR gamma | 1 | 2016 | 177 | 0.030 |
Why?
| | Longevity | 1 | 2017 | 173 | 0.030 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2017 | 198 | 0.030 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2016 | 169 | 0.030 |
Why?
| | Female | 2 | 2021 | 78376 | 0.030 |
Why?
| | Diet, High-Fat | 1 | 2016 | 261 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2017 | 509 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2017 | 1371 | 0.030 |
Why?
| | Electrocardiography | 1 | 2017 | 663 | 0.030 |
Why?
| | Hydrogen Peroxide | 1 | 2015 | 336 | 0.030 |
Why?
| | Superoxide Dismutase | 1 | 2015 | 301 | 0.020 |
Why?
| | Small Ubiquitin-Related Modifier Proteins | 1 | 2013 | 15 | 0.020 |
Why?
| | Consensus Sequence | 1 | 2013 | 74 | 0.020 |
Why?
| | SUMO-1 Protein | 1 | 2013 | 22 | 0.020 |
Why?
| | Retinoid X Receptors | 1 | 2013 | 38 | 0.020 |
Why?
| | Hep G2 Cells | 1 | 2013 | 75 | 0.020 |
Why?
| | Caco-2 Cells | 1 | 2013 | 79 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2013 | 224 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2016 | 780 | 0.020 |
Why?
| | Dietary Supplements | 1 | 2016 | 576 | 0.020 |
Why?
| | Methyltransferases | 1 | 2013 | 74 | 0.020 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2013 | 148 | 0.020 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2013 | 381 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2017 | 906 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2013 | 336 | 0.020 |
Why?
| | Amino Acid Substitution | 1 | 2013 | 304 | 0.020 |
Why?
| | Arginine | 1 | 2013 | 262 | 0.020 |
Why?
| | Protein Transport | 1 | 2013 | 441 | 0.020 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2013 | 220 | 0.020 |
Why?
| | Ligands | 1 | 2013 | 674 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2013 | 635 | 0.020 |
Why?
| | Blood Pressure | 1 | 2017 | 1769 | 0.020 |
Why?
| | Mitochondria | 1 | 2017 | 984 | 0.020 |
Why?
| | Cholestasis | 1 | 2013 | 219 | 0.020 |
Why?
| | Protein Processing, Post-Translational | 1 | 2013 | 477 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 4155 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2013 | 2157 | 0.020 |
Why?
| | Chromatin | 1 | 2013 | 561 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2017 | 2832 | 0.020 |
Why?
| | Rats | 1 | 2017 | 5614 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2013 | 2931 | 0.020 |
Why?
| | Protein Binding | 1 | 2013 | 2276 | 0.020 |
Why?
| | Biomarkers | 1 | 2017 | 4275 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2013 | 1500 | 0.010 |
Why?
| | Inflammation | 1 | 2017 | 2880 | 0.010 |
Why?
| | Pregnancy | 1 | 2016 | 7191 | 0.010 |
Why?
| | Signal Transduction | 1 | 2015 | 5233 | 0.010 |
Why?
| | Mutation | 1 | 2013 | 4099 | 0.010 |
Why?
|
|
Luo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|